Homeopathic medicines substantially reduce the need for clotting factor concentrates in haemophilia patients: results of a blinded placebo controlled cross over trial
Received22 March 2010
revised18 August 2011
accepted20 October 2011
21 December 2017 (online)
Background: Modern management of haemophilia patients is expensive: 90% of expenditure is on clotting factor concentrates. Any intervention which reduces the need for clotting factor concentrates in these patients without compromising the quality of life is of interest.
Aims and objectives: To investigate the effectiveness of individualised homeopathic medicines in reducing the requirement of factor concentrates in haemophilia patients.
Materials and methods: In a single blind placebo controlled cross over trial 28 consecutive persons with haemophilia (PWH) with severe (24) or moderately severe (4) disease received standard management with placebo homeopathy for 1 year and active homeopathic treatment in the subsequent year with the same conventional management. There was no wash out period. They received standard managements for any acute emergency during the study period. Development of inhibitor during the study period was a withdrawal criterion. Sample size for the trial was calculated as 24 PWH.
Transfusion requirements, bleeding scores, pain scores were evaluated blind by independent experts. Homeopathic medicines were selected by experienced homeopathic physicians depending on clinical condition of the patient. Chi-squared and paired t tests were used in statistical analysis.
Results: 28 patients were recruited. Homeopathic medicines improved frequency of bleeding, extent of bleeding, blood products consumed and pain scores (P < 0.0001). There was also significant improvement in well being. Plasma levels of clotting factors did not change. No patients developed inhibitors during the study there were no dropouts.
Conclusion: Individualised homeopathic medicines may have an important supportive role in the management of PWH, where blood products and factor concentrates are not easily available. Larger, perhaps multicentric trials are warranted.
- 1 Tezanos Pinto M., Ortiz Z. Haemophilia in the developing world: successes, frustrations and opportunities. Haemophilia 2004; 10 (Suppl. 04) 14-19.
- 2 Ghosh K., Shetty S., Sahu D. Haemophilia care in India: innovations and integrations by various chapters of Haemophilia Federation of India (HFI). Haemophilia 2010; 16: 61-65.
- 3 Kale J. Guide to exercises for haemophiliacs. Haemophilia Society Mumbai Mumbai, India: Bhalani Publishing House; 1999.
- 4 Kale J.S., Ghosh K., Mohanty D., Pathare A.V., Jijina F. Use of the dual force system to correct chronic knee deformities due to severe haemophilia. Haemophilia 2000; 6: 177-180.
- 5 Hahnemann S. Organon of medicine. 6th edn. New Delhi: B. Jain Publications; 1990. Aphorisms 83–104.
- 6 Kent J.T. Lectures in homoeopathic philosophy. Prognosis after administration of homoeopathic medicine. New Delhi: B. Jain Publications; 1998.
- 7 Wong DL, Hockenberry-Eaton M, Wilson D, Winkelstein ML, Schwartz P. Wong’s essentials of pediatric nursing, 6th edn, St. Louis, 2001, p 1301.
- 8 van Duijn G., Dijkxhoorn Y., Noens I., Scholte E., van Berckelaer-Onnes I. Vineland Screener 0–12 years research version (NL). Constructing a screening instrument to assess adaptive behaviour. Int J Meth Psychiatr Res 2009; 18: 110-117.
- 9 Ghosh K. Management of haemophilia and its complications in developing countries. Clin Lab Haematol 2004; 26: 243-251.
- 10 In: Lee C.A., Berntrop E.E., Keith Hoots W. Text Book of Haemophilia. 2nd edn. 2010. London: Willey Blackwell.;
- 11 Bottema C.D., Ketterling R.P., Yoon H.S., Sommer S.S. The pattern of factor IX germ-line mutation in Asians is similar to that of Caucasians. Am J Hum Genet 1990; 47: 835-841.
- 12 Kleijnen J., Knipschild P., Ter Riet G. Clinical trials in homeopathy. Br Med J 1992; 302: 316-323.
- 13 Shang A., Huwiler-Muntener K., Nartey L. et al. Are the clinical effects of homeopathy placebo effects? Comparative study of placebo-controlled trials of homeopathy and allopathy. Lancet 2005; 366: 726-732.
- 14 Novella S., Roy R., Marcus D., Bell I.R., Davidovitch N., Saine A. A debate: homeopathy – quackery or a key to the future of medicine?. J Altern Complement Med 2008; 14: 9-15.
- 15 Linde K., Clausius N., Ramirez G. et al. Are the clinical effects of homeopathy a placebo effect? A meta analysis of placebo-controlled trials. Lancet 1997; 350: 834-843.